Sharps Compliance Corp. (NASDAQ:SMED) Receives Consensus Recommendation of “Buy” from Brokerages
Sharps Compliance Corp. (NASDAQ:SMED) has been assigned a consensus recommendation of “Buy” from the six brokerages that are currently covering the company, Marketbeat Ratings reports. One analyst has rated the stock with a hold rating and four have given a buy rating to the company. The average 1 year price objective among analysts that have covered the stock in the last year is $5.00.
A number of analysts have recently weighed in on the company. Zacks Investment Research raised Sharps Compliance from a “hold” rating to a “buy” rating and set a $5.00 price objective for the company in a research report on Wednesday. Barrington Research reissued an “outperform” rating and issued a $6.00 price objective (up previously from $5.00) on shares of Sharps Compliance in a research report on Tuesday, October 29th. Finally, ValuEngine raised Sharps Compliance from a “sell” rating to a “hold” rating in a research report on Thursday, November 14th.
Shares of Sharps Compliance stock traded down $0.08 during trading on Friday, reaching $4.42. The company’s stock had a trading volume of 33,566 shares, compared to its average volume of 31,892. The company has a quick ratio of 1.66, a current ratio of 1.99 and a debt-to-equity ratio of 0.30. The company has a market cap of $72.66 million, a price-to-earnings ratio of 90.00, a P/E/G ratio of 3.33 and a beta of 0.23. Sharps Compliance has a 1-year low of $3.08 and a 1-year high of $5.25. The company has a 50-day simple moving average of $4.26 and a two-hundred day simple moving average of $4.07.
A number of hedge funds have recently modified their holdings of SMED. Wells Fargo & Company MN raised its stake in Sharps Compliance by 8.3% in the 2nd quarter. Wells Fargo & Company MN now owns 424,814 shares of the industrial products company’s stock worth $1,512,000 after acquiring an additional 32,600 shares during the last quarter. BlackRock Inc. raised its stake in Sharps Compliance by 3.8% in the 2nd quarter. BlackRock Inc. now owns 108,739 shares of the industrial products company’s stock worth $387,000 after acquiring an additional 4,013 shares during the last quarter. Morgan Stanley raised its stake in Sharps Compliance by 34.3% in the 2nd quarter. Morgan Stanley now owns 188,699 shares of the industrial products company’s stock worth $672,000 after acquiring an additional 48,199 shares during the last quarter. North Star Investment Management Corp. raised its stake in Sharps Compliance by 9.8% in the 3rd quarter. North Star Investment Management Corp. now owns 271,575 shares of the industrial products company’s stock worth $1,127,000 after acquiring an additional 24,150 shares during the last quarter. Finally, Sunbelt Securities Inc. purchased a new position in Sharps Compliance in the 3rd quarter worth $872,000. Institutional investors own 18.41% of the company’s stock.
Sharps Compliance Company Profile
Sharps Compliance Corp. provides medical, pharmaceutical, and hazardous waste management services in the United States. It offers Sharps Recovery System for the containment, transportation, treatment, and tracking of medical waste and used healthcare materials generated outside the hospital and health care facility settings; TakeAway Medication Recovery System, a solution that facilitates the proper disposal of unused medications; MedSafe, a solution for the safe collection, transportation, and proper disposal of unwanted and expired prescription medications; and ComplianceTRAC, a Web-based compliance and training program.
Receive News & Ratings for Sharps Compliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sharps Compliance and related companies with MarketBeat.com's FREE daily email newsletter.